Triple
T23186579
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | George D. Yancopoulos |
E579607
|
entity |
| Predicate | notableWork |
P4
|
FINISHED |
| Object | Regeneron’s VelociMouse technology |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Regeneron’s VelociMouse technology | Statement: [George D. Yancopoulos, notableWork, Regeneron’s VelociMouse technology]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Regeneron’s VelociMouse technology Context triple: [George D. Yancopoulos, notableWork, Regeneron’s VelociMouse technology]
-
A.
VelocImmune technology
chosen
VelocImmune technology is Regeneron’s proprietary platform that uses genetically engineered mice to rapidly produce fully human monoclonal antibodies for therapeutic development.
-
B.
ReadyNow technology
ReadyNow technology is a performance-optimization solution from Azul Systems that reduces Java application warm-up time and improves startup consistency by leveraging pre-compiled and profile-guided optimizations.
-
C.
G-Diffuser system
The G-Diffuser system is the advanced energy and gravity-control technology that enables Arwing starfighters in the Star Fox series to perform high-speed maneuvers and atmospheric re-entry without structural damage.
-
D.
HyperAcute cellular immunotherapy platform
HyperAcute cellular immunotherapy platform is a cancer treatment technology that uses genetically modified tumor cells to stimulate a strong immune response against cancer.
-
E.
Biomek liquid handling systems
Biomek liquid handling systems are automated laboratory instruments designed to streamline and precisely perform high-throughput liquid handling tasks such as pipetting, sample preparation, and assay setup.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e245ff8000819090d12008805315b7 |
completed | April 17, 2026, 2:38 p.m. |
| NER | Named-entity recognition | batch_69f18fd3aaa08190b9cf7afe4ee5a38d |
completed | April 29, 2026, 4:57 a.m. |
Created at: April 17, 2026, 4:05 p.m.